Тёмный

[Webinar] E9(R1) Addendum on Estimands: The Use of Estimand Framework for Oncology Clinical Trials 

OCT Clinical Trials
Подписаться 576
Просмотров 674
50% 1

After the draft E9(R1) Addendum on estimands and sensitivity analysis in clinical trials was first introduced, one of the most frequently asked questions was whether the proposed framework was applicable to Oncology clinical trials and time-to-event endpoints.
This webinar expands on how the estimand framework can help improve the way in which clinical trials are designed and planned, and how primary analyses and sensitivity analyses are appropriately conducted with an emphasis on the therapeutic area of Oncology and time-to event endpoints.
Feel free to reach out to OCT team to learn more at info@oct-clinicaltrials.com
Learn more about OCT Clinical's biometrics services here: oct-clinicaltrials.com/servic...
#cro #octclinical #biostatistics #biometrics

Наука

Опубликовано:

 

14 май 2023

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии    
Далее
PSI EIWG Webinar: Estimands in Oncology - How and Why
1:32:24
Это реально работает?!
00:33
Просмотров 2,5 млн
DO NOT go to MEDICAL SCHOOL (If This is You)
8:00
The moment we stopped understanding AI [AlexNet]
17:38
Просмотров 854 тыс.
[Efficacy] ICH E9
1:03:55
Просмотров 5 тыс.
Antibiotic Classes in 7 minutes!!
7:36
Просмотров 1,7 млн
iPhone socket cleaning #Fixit
0:30
Просмотров 18 млн